Chronic pancreatitis
Drug research and approvals for chronic pancreatitis: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 47 studies of chronic pancreatitis are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, and FDA has 0 approved and 5 open orphan designations naming it.
- Recruiting worldwide: 47
- Trials authorized in Canada: 0
- FDA orphan approvals: 0
- EU medicines: 0
- The imPAct of nutritioN on the Outcome of pancrEATic Surgery; Food for Thought.NCT07940309 · Not reported · Maastricht University Medical Center · starts Oct 1, 2026
- A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of CBT-248 in Healthy Adult…NCT07905053 · Phase 1 · Cibus Therapeutics, Inc. · starts Oct 15, 2026
- Diagnostic Utility of Protein Biomarkers in Pancreatic Ductal AdenocarcinomaNCT07875582 · Not reported · Grigore T. Popa University of Medicine and Pharmacy · starts Oct 8, 2026
- Inebilizumab for the Treatment of Patients With Type 1 Autoimmune PancreatitisNCT07862075 · Phase 4 · Ruijin Hospital · starts Oct 1, 2025
- Metabolic Impact of Pancreatic Duct DecompressionNCT07810309 · Phase 1 · Mayo Clinic · starts Oct 30, 2026
- Neural Sensitisation and Neuropsychological Alterations in Painful Chronic PancreatitisNCT07707609 · Not reported · Asian Institute of Gastroenterology, India · starts Jan 6, 2026
- Comparative Study to Evaluate Microbial Versus Porcine Pancreatic Enzyme Therapy in Chronic PancreatitisNCT07697352 · Phase 3 · Asian Institute of Gastroenterology, India · starts Oct 12, 2026
- EUS Procedures Using RIVOS™ EUS Access DeviceNCT07696572 · Not reported · Orlando Health, Inc. · starts Jul 13, 2026
- Validation of the Odesa Criteria 2026 for Autoimmune PancreatitisNCT07536841 · Not reported · Military Medical Clinical Center of the Southern Region, Ukraine · starts May 1, 2026
Phase 3 3
- PancrelipaseFatty acids hydrolytic enzyme
- BupivacaineSodium channel protein type IV alpha subunit blocker
- TriamcinoloneGlucocorticoid receptor agonist
Phase 2 6
- ThalidomideCRL4(CRBN) E3 ubiquitin ligase inhibitor
- PregabalinVoltage-gated calcium channel modulator
- Lipase (pancrelipase)Fatty acids hydrolytic enzyme
- ReparixinInterleukin-8 receptor A modulator
- TanezumabBeta-nerve growth factor inhibitor
- MS-1819
Phase 1 or earlier 6
- IndomethacinCyclooxygenase inhibitor
- SecretinSecretin receptor agonist
- EsomeprazolePotassium-transporting ATPase inhibitor
- .alpha.1-proteinase inhibitor humanLeukocyte elastase inhibitor
- ParicalcitolVitamin D receptor agonist
- SimvastatinHMG-CoA reductase inhibitor
How its trials ended
229 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 42 whose ending is known, 33% met their primary endpoint, 7% missed it and 60% stopped early.
- Completed, result not reported9039%
- Ongoing6729%
- Status unknown3013%
- Met its primary endpoint146%
- Stopped: other or unclear146%
- Stopped: enrollment or feasibility63%
- Missed its primary endpoint31%
- Stopped: lack of efficacy21%
- Stopped: sponsor or business decision21%
- Stopped: safety1<1%
| Oct 22, 2025 | Camostat mesilateTreatment of chronic pancreatitis | Pangenix Pharma Limited | Designated |
| Jul 1, 2024 | ProglumideTreatment of chronic pancreatitis | CCKr Therapeutics. Inc. | Designated |
| Sep 9, 2020 | ProglumideTreatment of Chronic Pancreatitis | RNR BioMedical Inc. | Designated |
| Sep 5, 2019 | PEGylated recombinant human tumor necrosis factor-related…Treatment of chronic pancreatitis. | Theraly Fibrosis, Inc. | Designated |
| May 18, 2011 | CamostatTreatment of chronic pancreatitis | NIXS Corporation | Designated |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA